Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

Completed

• Conditions: Vaccine Reaction; SARS-CoV2 Infection
• Interventions: Biological: Approved vaccines against Sars-Cov2

• Registration Number: NCT04954651
• Lead Sponsor: University of Patras

Brief Summary

Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-07-06
• Study First Submitted QC: 2021-07-06
• Study Start: 2021-07-07
• Study First Posted: 2021-07-08
• Primary Completion: 2022-03-28
• Study Completion: 2022-03-28
• Status Verified: 2022-06
• Last Update Submitted: 2022-06-02
• Last Update Posted: 2022-06-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Subjects who voluntarily receive COVID-19 vaccination

Exclusion Criteria

• Patients who do not complete their vaccination
• Patients who do not provide info on their health status

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
VAC	Approved vaccines against Sars-Cov2	Vaccinated subject against Sars-Cov2

Primary Outcome Measures

Name	Time	Method
Antibody titer against Sars-Cov2	0-9 months

Trial Locations

Locations (1)

University Hospital of Patras; 🇬🇷 Patras, Greece